<VariationArchive VariationID="1699935" VariationName="NM_002353.3(TACSTD2):c.653del (p.Asp218fs)" VariationType="Deletion" Accession="VCV001699935" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2022-11-29" MostRecentSubmission="2022-11-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1054172" VariationID="1699935">
      <GeneList>
        <Gene Symbol="TACSTD2" FullName="tumor associated calcium signal transducer 2" GeneID="4070" HGNC_ID="HGNC:11530" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p32.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="58575433" stop="58577252" display_start="58575433" display_stop="58577252" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="59041094" stop="59043165" display_start="59041094" display_stop="59043165" Strand="-" />
          </Location>
          <OMIM>137290</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_002353.3(TACSTD2):c.653del (p.Asp218fs)</Name>
      <CanonicalSPDI>NC_000001.11:58576503:T:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1p32.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="58576504" stop="58576504" display_start="58576504" display_stop="58576504" variantLength="1" positionVCF="58576503" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="59042176" stop="59042176" display_start="59042176" display_stop="59042176" variantLength="1" positionVCF="59042175" referenceAlleleVCF="AT" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>D218fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.59042176del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.59042176del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.58576504del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.58576504del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016237.1" sequenceAccession="NG_016237" sequenceVersion="1" change="g.5991del">
            <Expression>NG_016237.1:g.5991del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002353.3" sequenceAccession="NM_002353" sequenceVersion="3" change="c.653del" MANESelect="true">
            <Expression>NM_002353.3:c.653del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002344.2" sequenceAccession="NP_002344" sequenceVersion="2" change="p.Asp218fs">
            <Expression>NP_002344.2:p.Asp218fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002353.2" sequenceAccession="NM_002353" sequenceVersion="2" change="c.653del">
            <Expression>NM_002353.2:c.653del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="780819073" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="missing protein">
        <XRef ID="0240" DB="Variation Ontology" />
      </FunctionalConsequence>
      <FunctionalConsequence Value="loss_of_function_variant">
        <XRef ID="SO:0002054" DB="Sequence Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_002353.3(TACSTD2):c.653del (p.Asp218fs) AND Lattice corneal dystrophy Type III" Accession="RCV002460351" Version="2">
        <ClassifiedConditionList TraitSetID="5249">
          <ClassifiedCondition DB="MedGen" ID="C0339273">Lattice corneal dystrophy Type III</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-11-29" MostRecentSubmission="2022-11-29">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17167402</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="5249" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1565" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CDGDL</ElementValue>
                <XRef Type="MIM" ID="204870" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amyloidosis corneal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amyloid of cornea</ElementValue>
                <XRef ID="231928002" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Amyloid corneal dystrophy, Japanese type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Corneal dystrophy, Lattice type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lattice corneal dystrophy type3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Lattice corneal dystrophy Type III</ElementValue>
                <XRef ID="418946006" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">GDLD</ElementValue>
                <XRef Type="MIM" ID="204870" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9647" />
                <XRef ID="9647" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="98957" DB="Orphanet" />
              <XRef ID="C0339273" DB="MedGen" />
              <XRef ID="MONDO:0008777" DB="MONDO" />
              <XRef Type="MIM" ID="204870" DB="OMIM" />
              <XRef Type="primary" ID="HP:0034701" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5006392" SubmissionDate="2022-08-02" DateLastUpdated="2022-11-29" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="SUB11567989" submittedAssembly="GRCh38" title="SUB11567989" />
        <ClinVarAccession Accession="SCV002556359" DateUpdated="2022-11-29" DateCreated="2022-11-29" Type="SCV" Version="1" SubmitterName="Laboratory of Molecular Human Genetics, Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency" OrgID="508008" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">17167402</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Russian</Ethnicity>
              <GeographicOrigin>Russia</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <NamePlatform>ABI Prism 3730XL Genetic Analyzer</NamePlatform>
              <TypePlatform>Sanger sequencing</TypePlatform>
              <Description>Blood DNA was extracted using the Gentra Puregene Blood Kit (Qiagen; Hilden, Germany) according to the manufacturerâ€™s protocol. Primers for the protein coding sequence of TACSTD2 were as follows: for region NC_000001.11:g.58577245-58576846 - forward TGCAGACCATCCCAGACG, reverse TAGAGGCCATCGTTGTCCAC; for region NC_000001.11:g.58576944-58576545 - forward CAAGTGTCTGCTGCTCAAGG, reverse CTCGATCTGGATGGTGGGC; for region NC_000001.11:g.58576602-58576118 - forward GCTGCACCCCAAGTTCGT, reverse GCTGCACCCCAAGTTCGT. PCR was carried out using the Gene Pak PCR MasterMix Core Kit (IsoGene Lab. Ltd.; Moscow, Russia). BigDye Terminator v3.1 Kit (Thermo Fisher Scientific) with the ABI Prism 3730XL Genetic Analyzer (Applied Biosystems Inc.; Waltham, Massachusetts, USA) was used for Sanger sequencing. Sanger chromatograms were processed with Unipro UGENE, and Nucleotide BLAST software (provided in the public domain by the National Center for Biotechnology Information)</Description>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Homozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001131" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0007663" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000613" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000622" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000505" />
              </Trait>
              <Comment>Diagnosis was based on the following characteristic symptoms: grayish and yellow deposits under the epithelium and in the corneal stroma, vascularization, bilateral corneal lesions, and decreased visual acuity.</Comment>
            </TraitSet>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>not applicable</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not applicable</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
              <ObsMethodAttribute>
                <Attribute Type="MethodResult">Expi293F cells were transfected with vectors containing wild-type or mutant sequence, coding TACSTD2 protein. Cell lysate was used in western blot analysis with primary TROP2 polyclonal antibodies (#PA5-13638, Thermo Fisher Scientific). Analysis of bands revealed that c.653del results in synthesis of truncated protein. As predicted, c.653del leads to the generation of a premature stop codon, which in turn leads to the absence of the transmembrane domain. Analysis of subcellular localization with immunofluorescence staining showed the difference in distribution pattern between wild-type (mostly in cell membrane) and mutated protein (mostly in the cytoplasm). This confirms the c.653del variant deleterious effect on TROP2 protein function.</Attribute>
              </ObsMethodAttribute>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TACSTD2">
              <Name>tumor associated calcium signal transducer 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="rs780819073" />
          </XRefList>
          <FunctionalConsequence Value="loss_of_function_variant">
            <XRef DB="Sequence Ontology" ID="SO:0002054" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0002054" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_002353.2:c.653del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="204870" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11567989</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5006392" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000613" MappingRef="HP">
        <MedGen CUI="C0085636" Name="Photophobia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006392" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001131" MappingRef="HP">
        <MedGen CUI="C0010036" Name="Corneal dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006392" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000505" MappingRef="HP">
        <MedGen CUI="C3665347" Name="Visual impairment" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006392" TraitType="Disease" MappingType="XRef" MappingValue="204870" MappingRef="OMIM">
        <MedGen CUI="C0339273" Name="Lattice corneal dystrophy Type III" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006392" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000622" MappingRef="HP">
        <MedGen CUI="C0344232" Name="Blurred vision" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5006392" TraitType="Finding" MappingType="XRef" MappingValue="HP:0007663" MappingRef="HP">
        <MedGen CUI="C0234632" Name="Reduced visual acuity" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

